Sarepta reports second Duchenne patient death Read in browser

Thank you for reading, dupa dupackia! basic Subscription UPGRADE

Mon T W Th F 16 June, 2025

Supply chain strategy just got more complicated — is your manufacturing model still viable? Trade tensions, policy shifts, and geopolitical uncertainty have biopharma executives rethinking manufacturing and distribution. How are the experts doing it now? Find out — get your spot today.

spotlight In Focus With HIV prevention under attack, how might Gilead’s new PrEP injection fare?

news Sage's roller coaster ends in $561M acquisition by Supernus Sarepta halts Duchenne gene therapy in some patients after second death KalVista says FDA delayed decision on HAE drug, citing ‘heavy workload’  Lilly posts encouraging early-stage weight loss data on amylin candidate Former CEO Anne Wojcicki wins bid for 23andMe Gilead, Arcellx continue to spotlight safety of multiple myeloma cell therapy

Jun 18 12:00pm ET Illuminating the CKD patient journey: Clinicogenomic data reshapes research & drug discovery sponsored by Natera Jun 24 10:30am ET Expanding access, accelerating trials: The power of community-based oncology research sponsored by START Research Jun 26 11:00am ET May the (Power of the) Pool be with you: Accelerating time from DNA to GMP – STI based CLD Platform sponsored by Rentschler Biopharma Jul 10 11:00am ET Beyond the data deluge: Immune profiling in early immuno-oncology trails sponsored by Precision for Medicine Jul 22 2:00pm ET New data from ASCO 2025 & clinical performance of Natera’s ultra-sensitive MRD platform sponsored by Natera

endpoints pharma FDA's oncology adcomm to review GSK's Blenrep relaunch plans Another round of consolidation is coming, FDA commissioner tells staff

in case you missed it 1. AstraZeneca inks AI drug R&D deal with Chinese pharma for $110M upfront  2. Peer Review Bristol Myers gets a key strategist with 'Team Shibs'; Idorsia to change CEOs after it 'hit a reset button' 3. News Briefing Rein Therapeutics study on clinical hold; Beam updates sickle cell therapy data 4. China Joins US in Brain Implant Race With Clinical Trial

.